Sawai Group Holdings Co., Ltd. (TYO:4887)
1,749.00
+14.50 (0.84%)
May 29, 2026, 3:30 PM JST
Sawai Group Holdings Revenue
In the fiscal year ending March 31, 2026, Sawai Group Holdings had annual revenue of 201.68B JPY with 6.69% growth. Sawai Group Holdings had revenue of 46.81B in the quarter ending March 31, 2026, with 2.17% growth.
Revenue
201.68B
Revenue Growth
+6.69%
P/S Ratio
1.00
Revenue / Employee
60.93M
Employees
3,310
Market Cap
201.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 201.68B | 12.65B | 6.69% |
| Mar 31, 2025 | 189.02B | 12.16B | 6.88% |
| Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
| Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
| Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Toho Holdings | 1.55T |
| Sumitomo Pharma | 453.29B |
| Towa Pharmaceutical | 273.71B |
| Tsumura & Co. | 192.62B |
| Nippon Shinyaku | 170.77B |
| KYORIN Pharmaceutical | 126.26B |
| Mochida Pharmaceutical | 116.95B |
| Kissei Pharmaceutical | 97.41B |